D Boesch
Impact in
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
-
- Pharmacological Effects and Toxicity Studies
Papers in
-
- Cancer therapeutics and mechanisms 3
- Synthesis and bioactivity of alkaloids 3
- RNA Interference and Gene Delivery 2
- Biochemical and Structural Characterization 1
- Biochemical and Molecular Research 1
- Oncology 5
- Drug Transport and Resistance Mechanisms 5
- Co-authors
- Francis Loor (8 shared papers)Claire Gavériaux‐Ruff (5 shared papers)B Jachez (4 shared papers)A Pourtier-Manzanedo (2 shared papers)Pietro Bollinger (2 shared papers)M. A. Grassberger (3 shared papers)T.G. Payne (1 shared paper)Peter Hiestand (1 shared paper)
- Journals
- Anti-Cancer Drugs (3 papers)British Journal of Cancer (2 papers)Experimental Cell Research (1 paper)Molecular & Cellular Proteomics (1 paper)Journal of Medicinal Chemistry (1 paper)
- Partner nations
- SwitzerlandFranceAustria
In The Last Decade
D Boesch
10 papers receiving 611 citations
Peers
Comparison fields: 5 of 68
- Oncology 513
- Pediatrics, Perinatology and Child Health 180
- Infectious Diseases 116
- Pharmacology 46
- Molecular Biology 319
Countries citing papers authored by D Boesch
This map shows the geographic impact of D Boesch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Boesch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Boesch more than expected).
Fields of papers citing papers by D Boesch
This network shows the impact of papers produced by D Boesch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Boesch. The network helps show where D Boesch may publish in the future.
Co-authors
The 20 scholars most cited alongside D Boesch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | In vivo circumvention of P-glycoprotein-mediated multidrug resistance of tumor cells with SDZ PSC 833. | 1991 | 322 |
| 2 | 1991 | 115 | |
| 3 | 1989 | 55 | |
| 4 | 1992 | 42 | |
| 5 | 2008 | 36 | |
| 6 | 1994 | 22 | |
| 7 | 1993 | 16 | |
| 8 | 1994 | 13 | |
| 9 | 1994 | 6 | |
| 10 | 1994 | 2 |
About D Boesch
D Boesch is a scholar working on Molecular Biology, Oncology, Pharmacology, Immunology and Infectious Diseases, having authored 10 papers that have together received 629 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (5 papers), Cancer therapeutics and mechanisms (3 papers), Synthesis and bioactivity of alkaloids (3 papers), Toxin Mechanisms and Immunotoxins (2 papers), RNA Interference and Gene Delivery (2 papers), Pharmacological Effects and Toxicity Studies (1 paper), Biochemical and Structural Characterization (1 paper) and Biochemical and Molecular Research (1 paper). The work is most often cited by research in Oncology (513 citations), Pediatrics, Perinatology and Child Health (180 citations), Infectious Diseases (116 citations), Pharmacology (46 citations) and Molecular Biology (319 citations). D Boesch has collaborated with scholars based in Switzerland, France and Austria. Frequent co-authors include Francis Loor, Claire Gavériaux‐Ruff, B Jachez, A Pourtier-Manzanedo, Pietro Bollinger, M. A. Grassberger, T.G. Payne, Peter Hiestand, René Traber and Roland M. Wenger. Their work appears in journals such as Anti-Cancer Drugs, British Journal of Cancer, Experimental Cell Research, Molecular & Cellular Proteomics and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.